Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E4EP
|
||||
Former ID |
DIB010284
|
||||
Drug Name |
Oncolysin M
|
||||
Synonyms |
Anti-CD33-bR; Anti-My9-bR
|
||||
Indication | Leukemia [ICD9: 208.9; ICD10:C90-C95] | Discontinued in Phase 1 | [545607] | ||
Company |
Dana-Farber Cancer Institute Inc
|
||||
CAS Number |
CAS 339532-30-8
|
||||
Target and Pathway | |||||
Target(s) | Myeloid cell surface antigen CD33 | Target Info | Modulator | [550922] | |
KEGG Pathway | Hematopoietic cell lineage | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.